Medical care for HIV infection in France in 2005, the NADIS cohort study on 7416 patients;Prise en charge de l'infection à VIH en 2005 en France à travers 7416 patients de la cohorte NADIS

Medecine et Maladies Infectieuses

Volumn 36, Issue 9, 2006, Pages 454-459

  Poizot Martin, I ^a   Pugliese, P ^b   Enel, P ^a   Cuzin, L ^c   Billaud, E ^d   Duvivier, C ^c   Yazdanpanah, Y ^e  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c INSERM   (France)

^d HÔTEL DIEU   (France)

^e Tourcoing Hospital   (France)

Author keywords

AIDS; Antiretroviral therapy; HIV; Medical care

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; EVALUATION; FEMALE; FRANCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; RETROSPECTIVE STUDY; THERAPEUTIC COMMUNITY; VIROLOGY; VIRUS DETECTION; VIRUS LOAD; CLINICAL TRIAL; COMPUTER PROGRAM; DISEASE TRANSMISSION; HETEROSEXUALITY; HOMOSEXUALITY; INCIDENCE; MULTICENTER STUDY; RISK FACTOR; STATISTICS;

ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; FRANCE; HEPATITIS B; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY; HUMANS; INCIDENCE; MALE; RISK FACTORS; SOFTWARE;

EID: 33749997397     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.07.003     Document Type: Article

References (10)

1. INSERM EMI 0214. Retour d'Informations Clinicoépidémiologiques (RICE) (2004) 13
2. Département des maladies infectieuses, unité VIH/sida-IST-VHC, Institut de Veille Sanitaire, Saint Maurice, avec la collaboration du centre National de référence pour le VIH, Tours. Surveillance de l'infection à VIH-sida en France, 2003-2004. BEH 46-47 (2005) 230-233
3. Pugliese P., Cuzin L., Enel P., et al. NADIS 2000, développement d'un dossier médical informatisé pour les patients infectés par VIH, VHB, VHC. Presse Med. 32 (2003) 299-303
4. Agher R., Duvivier C., Katlama C., Gérard Y., Yazdanpanah Y., Billaud E., et al. Cohorte NADIS : 6236 patients séropositifs dans des CHU de France. Med Mal Inf 35 7-8 (2005) 407-410
5. Friis-Moller N., Weber R., Reiss P., et al. Cardiovascular disease risk factors in HIV patients -association with antiretroviral therapy. Results from the DAD study. AIDS 17 8 (2003) 1179-1193
6. Lichtenstein K.A., Ward D.J., Moorman A.C., et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15 11 (2001) 1389-1398
7. Afssaps. Prise en charge thérapeutique du patient dyslipidémique. Argumentaire. Les facteurs de risque. http://afssaps.sante.fr/pdf/5/rbp/dysarg.pdf. Mars 2005.
8. Recommandations du groupe d'experts sous la direction du Pr J.-F. Delfraissy. Prise en charge thérapeutique des personnes infectées par le VIH. Rapport 2004 (2004), Flammarion Médecine-Sciences
9. Lafeuillade A, Hittinger G, Delbeke E, Poggi C. Resistance selection in patients with stable low levels of HIV-1 viremia. In: XV International Conference on AIDS; Bangkok, Thailand; 2004. Abstract WeOrB1293.
10. Madec Y., Boufassa F., Porter K., et al. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 19 17 (2005) 2001-2007